VCs at MedCity INVEST Digital Health said there’s no shortage of interesting digital health companies, even ones that can prove their innovations are effective. The challenge is winning over insurers and physicians, and finding payment models that work.
The call to action is that point-of-care testing needs to move to the home and it needs to be supported by a Medicaid or Medicare billing code to support insurance coverage and payment for the testing.
The agency has granted certain Medicare quality reporting exceptions to healthcare facilities in areas of Louisiana, Mississippi, New York and New Jersey that were battered by Hurricane Ida. By providing the exceptions, CMS aims to enable facilities to direct their resources toward recovery.
Atopic dermatitis patients now have a new option that comes as a topical cream. The FDA approved Incyte’s drug, Opzelura, as a treatment for the inflammatory skin condition, but the regulatory nod comes with a black box warning on the label that broadly covers the entire class of JAK inhibitors.
Leaders with insurers and health systems said that taking a holistic approach and partnering with community organizations is key to standing up a successful social determinants of health program at a panel discussion hosted by MedCity INVEST Digital Health.
The company, which helps health systems operate virtual care programs through its platform, will use the new funds to scale its go-to-market efforts, invest in the development of new capabilities and hire new employees.
Walgreens bought a 71% stake in Shields Health Solutions, which strikes partnerships with hospitals to run specialty pharmacy programs. Walgreens has the option to buy the remaining equity interests in the future.
Unite Us will integrate NowPow’s tools and community partners into its closed-loop referral system, which can be used to screen for social factors that negatively affect health, like food or housing insecurity, and then electronically refer patients to resources in their community.
Which is more important when working with healthcare AI detection: that it never misses something on a patient scan, or that it never identifies something that isn’t there?
The Seagen and Genmab antibody drug conjugate (ADC), named Tivdak, is approved to treat cases of cervical cancer that have returned or spread following treatment with chemotherapy. Tivdak is Seagen’s third ADC; for Genmab, the drug will become its first commercialized product.
Inheret CEO and Founder Dr. David F. Keren talks about the origins of the cancer risk detection platform and his mission to identify hereditary diseases early.
Reaching out to and connecting with communities of color is a moral imperative. It’s a business imperative. For the healthcare system, it is no longer an option in an increasingly multicultural society.
Consumers want the healthcare industry to meet them where they are, and this shift in patient mindset has expanded the definition of home healthcare and who benefits from it, according to a panel at MedCity INVEST Digital Health conference.
The agency reminded health apps and wearables companies that they must disclose any breach of users’ health information, even if they are not a HIPAA covered entity. Companies that fail to disclose a breach could face thousands of dollars per day in fines.
Frank Westermann sold his previous startup, mySugr, to Roche four years ago. Now, he’s starting a new company with the goal of making healthcare providers and diabetes medications more accessible.
Along with daily surveys, a research team from Mount Sinai used Apple Watches to measure how stress impacted healthcare workers’ bodies and pinpointed the characteristics that were associated with lower stress levels over time.
A lower-dose version of Pfizer and BioNTech’s Covid-19 vaccine showed safety and efficacy results in children 5 to 11 that were comparable to those in an older age group. With these preliminary data, the companies said they plan to seek emergency use authorization of the shots.
Healthcare brands invest enormous sums of money in marketing campaigns, websites, and apps that will never be effective until a consumer can overcome the data barriers to healthcare access.
INVEST Digital Health kicks off today and runs through September 23. Held in a virtual format due to Covid-19, the healthcare conference brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups. Register today!
Bioprocessing technologies company Repligen is acquiring Avitide, and its biologics purifying technology, in a $150 million cash and stock deal. Repligen said Avitide will help it meet growing demand for gene therapy solutions.
The agency has suspended enrollment in three UnitedHealthcare plans and one Anthem plan for 2022 because the plans did not spend enough of their premium incomes on medical benefits and claims. The payers can contest the suspension, though it is unclear if they plan to.
As hospitals and health systems redefine and deliver consumer-oriented care, those that understand the value of the patient experience will emerge as leaders in the post-pandemic healthcare market.
The startup, which has a cleared device to reduce tremors using electrical stimulation, recently shared the results of a post-market analysis showing device use and efficacy.
An FDA advisory panel voted down a proposal for booster shots of the Pfizer/BioNTech Covid-19 in the general population, opting instead to support third shots in certain high-risk groups, such as the elderly. Panelists want to see more information supporting the need for a booster, as well as data about a heart safety risk the …
With the results of a recent trial Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalization of patients with heart failure. It’s also hoping to win over national coverage from CMS.
The practice, which initially will only be offered to CareFirst BCBS commercial members, provides an array of services, including preventive care, insurance navigation and behavioral and mental health services. Patients will be referred to in-person care with local providers when needed.
Rune Labs developed software that aggregates brain data, providing insights for clinical care and clinical research. Health systems are starting to adopt the technology, and the startup has now raised $22.8 million to grow that part of the business while also expanding use of the technology in drug development.
Check out new developments from HealthMine, Kiiio, Cured, Hinge Health and more.
If the merger is approved, the combined health system will operate 33 hospitals and 385 clinics across six states. The merger also represents the joining together of a faith-based organization, SCL Health, and a secular entity, Intermountain.
A previous investigation by MedCity News found that ElectrifAi was touting an improperly-developed algorithm during the earliest phase of the Covid-19 pandemic, with both the company and CEO defendants in an employment discrimination lawsuit. A year later, lawsuits are piling up as more former employees complain that the company and CEO lied about its AI …
The company, which offers mental health solutions for employers and health plans, recently closed a $190 million series C round, that included both equity and debt. It also brought on Guardian Life as a strategic investor.
This new type of ransomware — which was linked to a cyberattack against an Ohio-based health system in August — employs a multi-pronged approach, focusing not only on encrypting sensitive data but also on terminating backup processes to make it harder for organizations to recover from the attack.
Takeda Pharmaceutical drug mobocertinib was approved by the FDA to treat non-small cell lung cancer in patients whose tumors carry a rare genetic signature. With the approval, Takeda can offer an oral alternative to a recently approved Johnson & Johnson drug that targets the same mutation but is given as an infusion.
INVEST Digital Health is set for September 20-23. Held in a virtual format due to Covid-19, the healthcare conference brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.
After closing a series C round led by 8VC, Flywheel used a portion of the funds to acquire St. Louis-based Radiologics. Both have platforms to help researchers process medical imaging data.
Dice Therapeutics raised $204 million from its IPO to support development of oral drugs that could compete against biologic drugs that are injected or infused. Also debuting on the public markets were Tyra Biosciences and Procept BioRobotics.
The lawsuit alleges that an Aetna policy discriminates against LGBTQ people by requiring them to pay thousands in out-of-pocket costs for fertility treatments before becoming eligible for coverage. Though Aetna has agreed to pay the costs incurred by the plaintiffs, the suit aims to strike down the policy as a whole.
The cost of hospital care for unvaccinated Covid-19 patients has more than doubled, jumping from about $2 billion to $5.7 billion over the summer. And this figure may still be lower than the actual cost burden unvaccinated people represent to the healthcare system.
Tia, a concierge clinic combining primary care and OBGYN services, recently raised $100 million in funding. Amid a surge of financing into women’s health startups, CEO Carolyn Witte said investors’ perspectives are changing.
Enforcement of the No Surprises Act is still a work in progress, but CMS is ready to give out As for effort. Whether patients will agree with that grade still remains to be seen.
The clinical trial failure of Theravance Biopharma’s most advanced internal program, a drug for a rare blood pressure disorder, is leading to a companywide restructuring. Going forward, the biotech will focus on developing drugs for respiratory disorders.
After pushing back the start date twice, CMS now wants to scrap the Trump-era rule, which provides an expedited pathway to Medicare coverage for devices that receive the FDA breakthrough designation.
Vanqua Bio aims to treat rare form of Parkinson’s disease by boosting activity of an enzyme that is deficient in patients who have a particular genetic mutation. With $85 million in Series B financing, the biotech startup, which is based on Northwestern University research, aims to reach human testing within two years.
We’ve already broken down the traditional walls of healthcare, and if we invest in the right tools, we can continue shifting to a more streamlined, efficient, and patient-first care model.
Cincinnati-based IncludeHealth launched a virtual physical therapy program using pose-estimation models developed by Google. It plans to offer this software to healthcare providers, starting with its largest partner to date, ProMedica Health System.
Through the partnership, Highmark members will gain access to a personalized digital program that aims to reduce harmful drinking. The program includes virtual visits, medication-assisted treatment and coaching support.
The death occurred less than two weeks after Astellas Pharma reported that the patient developed liver problems after being dosed with the experimental gene therapy for a rare neuromuscular disorder. Astellas said the cause of death is still under investigation, and the FDA has placed a clinical hold on the study.
Luminopia, a startup with a digital therapeutic for amblyopia, or lazy eye, recently published the results of a phase 3 study showing its TV-based treatment can improve vision in kids’ non-dominant eye. Patients don a headset where images are altered to make them use both eyes.
CMS has recently proposed essential and timely reimbursement changes to close the racial discrepancy gap around the mandatory payment model for kidney disease
Who made the finals for this INVEST Digital Health Pitch Perfect track? Read about these digital health companies and check out the virtual event from September 20-23. Register today!
The maternal care startup is backed by major health systems including MemorialCare Health System, whose innovation arm led the most recent funding round. Babyscripts offers a mobile app providing education and resources for the pregnancy and postpartum journey.
Walking Fish Therapeutics is developing cell therapies from B cells, a type of immune cell that produces prodigious amounts of proteins. Cancer, autoimmune disease, and regenerative medicine are among the targets of the preclinical-stage biotech, which unveiled $50 million in funding.
A review of 12 studies about AI systems used to screen patients for breast cancer found that they lacked evidence to prove that they would work well in a clinical setting. Researchers highlighted concerns about study quality, including the fact that all of the studies were retrospective and many of them had a high risk …
In a set of newly proposed rules, HHS wants insurers offering individual and short-term, limited-duration coverage to disclose to members the rates they pay to brokers who help people select health plans. The government also wants to collect air ambulance data to help curb the high and unexpected costs that arise from these services.
AbbVie will take the lead on commercializing Regenxbio’s gene therapy in wet AMD and diabetic retinopathy. It’s AbbVie’s second major gene therapy deal this year, coming months after it committed $90 million to preclinical-stage Capsida Biotherapeutics.
Covid-19 exposed serious weaknesses in the American healthcare system, and has taken an unfortunate personal and economic toll on the entire world. But in the end, I do believe that our healthcare system will emerge more accessible, affordable, and effective
The telehealth giant struck a partnership with Proximie, which uses augmented reality to let clinicians virtually “scrub in” to operating rooms.
As more connected medical devices are built on AI, cybersecurity risks will increase as well – and it’s more important than ever before for manufacturers to implement advanced security protections in the design phase to ensure the safety of healthcare organizations, providers and patients.
The company, which partners with health systems and schools to provide virtual therapy services for kids, will use the Series A funds to expand. The round was led by New Capital Partners, with participation from LRVHealth and OSF Ventures.
Acknowledging the demand for a Covid-19 vaccine for children, the FDA said it expects regulatory review could take weeks, not months, depending on the timing of a submission from vaccine developers. U.S. health officials told Reuters they expect the Pfizer/BioNTech vaccine will be the first one ready for an FDA submission.
Four digital health leaders debated the role of self care apps, coaches and therapists in mental health during a panel at “What’s Next in Health Care?” While some touted the broader reach of self-guided treatments, others noted it was critical to have a therapist available for patients who need it.
The FDA issued a warning letter to Kaleido Biosciences alleging the company tested its experimental microbiome product in Covid-19 patients without submitting a formal clinical trial application. Kaleido claims the filing was not required because the product is a medical food, but the regulator doesn’t buy that argument.
CMS, in collaboration with the CDC, is making it mandatory for staff at healthcare facilities participating in Medicare and Medicaid programs to get vaccinated against Covid-19. The move comes as cases rise to 150,000 and deaths to 1,500 per day.
Older adults — especially those with a psychiatric comorbidity or uncontrolled pain — have a higher suicide rate compared with younger adults with the highest rate among males ages 65 and older.
Check out new developments from Emulate, HealthMine, LuminDx, and more.
Biotech startup iECURE is based on work from the University of Pennsylvania scientist, who has been researching ways to use in vivo gene editing as a way to “knock in” healthy versions of a gene to treat rare liver diseases. The company, which will develop therapeutic candidates from Penn, has raised $50 million in Series …
They made up 4.5% of total claims in June, according to a report by FAIR Health, compared to 13% of claims in April of 2020.
The Biden administration has issued a legal challenge to invalidate the controversial Texas law that bans abortions after six weeks of pregnancy claiming that it will strip residents of their constitutional rights.
When CMS overpays for services, providers and commercial payers are responsible for paying the agency back, and at times, they are on the hook for millions of dollars. But technology can help healthcare stakeholders catch the mistakes that lead to overpayments, thereby reducing unnecessary costs.
The funding round boosted Flo’s valuation to $800 million. It plans to put the funds toward new technical capabilities and new hires.
There is no single driver of low-value care — providers, systems, and patients all play a role. But with the right tools, stakeholders can work together to re-align incentives and transform our healthcare delivery system into one that prioritizes value, eliminates waste and leads to better overall patient outcomes.
Given the growing interest specialty providers are showing in virtual visits, health plans should ensure that their telehealth offerings include consumer access to a wide breadth of specialists.
Neuroglee recently raised $10 million in funding and struck a partnership with Mayo Clinic. It’s building a digital therapeutic and virtual programs for people with mild cognitive impairment.
A-Alpha Bio’s technology analyzes millions of protein-protein interactions simultaneously, a capability that speeds up drug discovery research. Biotech industry partners are already using the technology and now with $20 million in Series A funding, the startup plans to build machine-learning capabilities to crunch the data produced by all of those protein interactions.
The algorithm maps interactions between different areas of the brain, which can help guide the placement of electrodes for stimulating devices to treat brain diseases, like epilepsy, and movement disorders.
After piloting its primary care and urgent care service, Amazon Care, the tech giant started opening it to other companies in Washington. Now, Amazon is looking to expand the service to 20 other metros, according to Insider.
Not only do a majority of the top 20 hospitals on U.S. News & World Report’s 2020-21 Best Hospitals rankings not offer online scheduling, but about 65% also do not provide new patients the option to schedule a virtual visit online, despite strong consumer preference for digital access to healthcare.
Looking at how hospitals changed during Covid-19 is a starting point for a lot of larger questions in the healthcare industry.
Providers must recognize that each data point from a medical device has intrinsic value if harnessed properly. The tools exist now to extract more value from medical device data for providers and patients.
The app provides users with a personalized recovery plan, education materials and virtual access to a care team that includes behavioral health specialists. The NorthShore system will conduct a clinical trial to test the app after which it will decide whether to deploy the solution across its hospitals.
Combining the two companies would allow patients to access genetic testing and their health records in one place, and make it easier for Invitae to collect and organize health records.
The startup, founded by several former Trulia executives, builds software to help healthcare providers with administrative tasks, including scheduling, registration and price transparency.
Roche is partnering with Adaptimmune Therapeutics to develop allogeneic cell therapies based on Adaptimmune’s technology. In addition to these “off-the-shelf” products, the partners will also develop a personalized allogeneic cell therapy designed specifically for a patient’s cancer.
Chief medical information officers are in a unique position to help their organizations fight the Covid-19 pandemic — from setting up IT systems to support Covid testing, care and vaccination to helping fight fast-spreading misinformation.
Ultimately, digital health solutions will be critical to empowering informed connected healthcare consumers to proactively self-manage their care and be part of the solution for combatting the growing providers supply shortage.
A Phase 1/2 study of BioMarin Pharmaceutical’s gene therapy for phenylketonuria has been placed under a clinical hold after interim results from a preclinical study showed that some mice developed liver tumors. Patients did not receive the same high dose that was given to the mice, and no one in the clinical trial has developed …
Unleashed from restrictive norms for recruiting and interacting with patients, researchers are finding ways to bring more people into trials by simply making enrollment and participation accessible beyond restraints like geography and availability during “business hours.”
The healthcare conference, held in a virtual format due to Covid-19, brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.
Modulus Therapeutics recently emerged from stealth with technology from various disciplines and seed funding that the startup is using to develop better cell therapies. Natural killer cells directed against breast cancer is Modulus’s initial focus, but the startup says its approach can apply to multiple types of immune cells and multiple types of cancer.
As the popularity of digital healthcare only continues to grow, the innovative entrepreneurs who balance all factors of the ‘consumer’ patient experience will find the highest adoption.
Apple has integrated with 700 providers for its health records app. But it faces a similar challenge to other health records projects that have failed in the past: patient uptake.
In a new study, researchers suggest ACOs are not helping CMS save substantial amounts of money as they were expected to do, so the model should be eliminated. But other experts in the industry disagree, taking issue with the study’s methods and conclusions.
According to STAT News, CityBlock raised a $400 million funding round led by SoftBank. It plans to put the capital toward its goal of serving 10 million members by 2030.
As a result of digital health adoption soaring during the pandemic, health tech companies looking to hire a new CEO face more competition, but here are some tips to successfully hire the right leader who can navigate the inflection points of growth and steer digital health companies to success.
The FDA improved an Impel NeuroPharma migraine treatment, a nasal spray intended to bring pain relief more quickly than drugs administered in other ways. It marks the first approval for the Seattle company, which has developed a proprietary nasal delivery technology.
UnitedHealthcare is planning to participate in the ACA insurance exchanges in Alabama, Florida, Georgia, Illinois, Louisiana, Michigan and Texas. This will bring its total ACA marketplace footprint to 18 states.
According to a report by the Wall Street Journal, Apple is planning to add more health features to its watch, including a feature to track blood pressure and a wrist-based thermometer.
The lawsuit alleges that UPMC and the chair of its cardiothoracic surgery department knowing submitted false claims for concurrent surgeries that violated regulations. But, according to UPMC, there is no regulation that prohibits overlapping surgeries or billing for them.
Healthcare organizations demonstrated tremendous vision, innovation and flexibility as they navigated unprecedented challenges brought on by the pandemic. However, the challenges and changes to the healthcare industry will continue long after Covid-19 disappears.
For HIPAA to remain relevant for the next 25 years, policymakers and healthcare providers will need to remain agile and alert; this groundbreaking legislation will only be effective for as long as it keeps pace with the newest technologies and security challenges.
A Novartis drug intended to prevent organ rejection has failed to beat out the standard of care therapy in a Phase 2 study in kidney transplant patients. Other clinical trial failures announced ahead of the Labor Day weekend include a Forte Biosciences atopic dermatitis drug, as well a cancer therapy from Takeda Pharmaceutical.
Tools like eConsent provides organizations with an efficient and streamlined way to garner consent from study participants. Removing this barrier can help improve engagement and deeper the pool of potential participants.
The San Diego-based company began marketing its first product, a portable Covid-19 test, after receiving an emergency use authorization last year. Now, it’s filing the initial paperwork to go public as it scales up manufacturing.
Through the partnership, Ochsner Health’s Medicare Advantage patients will gain access to Bold’s platform, which assesses current fitness levels to create a personalized exercise program for users.
A Roche drug that failed as a treatment for neurological disorders is now the lead program for Disc Medicines. CEO John Quisel said Roche’s clinical data showed the small molecule’s promise addressing a rare blood disorder and now the biotech startup has $90 million to advance that drug and another one into Phase 2 testing.
A majority of organizations (93%) said they are focused on both attracting and retaining top talent, a new survey from Aon shows. They are offering various benefits to do so, including onsite or near-site health clinics for employees.
It’s time to embrace electronic prior authorization that, according to a 2021 AHIP study, has been found to reduce the mean time from PA request to decision by 69%. In addition, 71% of providers using ePA reported “faster time to patient care.”
The company rolled out a tool to help pharmaceutical companies pull together information about clinical trial sites and identify the best physician investigators for a trial.
INVEST Digital Health is set for September 20-23, and held in collaboration with Medical Alley. The healthcare conference, held in a virtual format due to Covid-19, brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.
Four patients dosed with an experimental Assembly Biosciences hepatitis B treatment developed high levels of liver enzymes, a sign of drug-induced liver toxicity. The biotech has decided to stop further work on that drug and focus instead on developing its other clinical-stage hepatitis B drugs.
By establishing a virtual relationship with consulting telepsychiatrists, psychiatric nurse practitioners, and licensed clinical social workers, PCPs and their behavioral care managers have access anytime to the appropriate support for patients’ mental health needs.
The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis.
Dubbed the Akron Children’s Health Collaborative, the pediatric ACO will focus on improving care for the approximately 100,000 children in Ohio covered by Medicaid whose benefits are managed by CareSource.
The company recently finished a study showing patients in the U.K. who used both Sleepio’s app and therapy saw improvements in anxiety and depression compared to people who used therapy alone. But the study also had several limitations.
The FDA’s review of a post-marketing study for Pfizer blockbuster anti-inflammatory drug Xeljanz found a higher risk of cardiovascular problems and cancer, and the agency is requiring additional warnings flagging those risks. The updated warnings extend to AbbVie and Eli Lilly medicines in the same drug class.
The latest report from the Medicare Board of Trustees shows that the health insurance trust fund, also known as Medicare Part A, will run out in a mere five years, which is in line with reports released in 2018, 2019 and 2020, indicating that the Covid-19 pandemic has not hastened the fund’s depletion.
Done right, digital transformation in healthcare drives productivity, satisfaction, quality of care, and reimbursement—but it can be easy to get wrong.
Neutralizing the next threat to public health requires a new mindset, a new development path that uses computers and algorithms working in concert with patients, physicians, and scientists.
Five months after raising $55 million to back a new technology and a promising lead cancer immunotherapy, Asher Biotherapeutics has reeled in $108 million more. CEO Craig Gibbs said investors were enticed by encouraging new data suggesting Asher Bio’s lead program is superior to a competitor’s.
Alma, a startup building tools to help therapists grow their practices and take insurance, raised $50 million in funding. It’s drummed up more than 2,000 therapists on its membership-based platform.
Johnson & Johnson reported results from a mid-stage study in southern Africa showing just 25% efficacy for its HIV vaccine. J&J developed the HIV vaccine with the same technology used in its successful Ebola and Covid-19 vaccines.
Johnson & Johnson Impact Ventures and Village Capital launched their first accelerator focused on culturally competent care this summer. Two startups were each awarded $100,000: Omaiven Health and Lucia Health Guidelines.
Novartis was unsuccessful developing bimagrumab as a treatment for a rare muscle disorder, but additional tests showed encouraging results in fat reduction. Startup Versanis Bio licensed rights to the antibody and plans to use its Series A financing for clinical trials testing the drug in obese patients.
The California-based health system will pay a hefty price to resolve allegations that it knowingly submitted inflated diagnosis codes for certain Medicare Advantage beneficiaries to receive higher payments. Sutter Health does not admit any liability in the matter.
Innovaccer helped Elevate Health overcome three substantial care coordination obstacles.
After more than a year’s worth of interviewing external experts, the Pivot podcast is turning its gaze inward to demystify — as much as possible — why we write the stories we write.
Clinical decision support systems don’t need to be distracting. We can design them to stop pointing out the patients in the middle of catastrophe, and start helping us prevent them from ever arriving there.
Read more to find out which finalists will present in the Home Health track of the startup pitch contest during the virtual conference, scheduled for September 20-23.
The startup, where patients access cash-pay telehealth and in-person visits, recently added prescription delivery through Truepill. It’s offering a list of generic medications for $5.
CMS will provide $80 million to 60 organizations that train ACA navigators — who help consumers find coverage on the federally funded marketplaces — in the 2022 plan year, up from 30 organizations that received $10 million this year.
One of science’s great puzzles is being solved by artificial intelligence and the answers shared freely on the internet. How can life sciences companies make the most of DeepMind’s discoveries while protecting their own?
Tie-ups of candy makers and nutritional product companies into a single firm called Bettera has culminated in a $1 billion acquisition by Catalent. The global contract manufacturing giant plans to leverage Bettera’s ability to produce gummies and chewables as a way to offer its customers new formulation options for nutraceutical products.
Telehealth startup Genome Medical recently raised $60 million in funding led by Casdin Capital. It’s using part of the funds to acquire GeneMatters, which would add more genetic counselors to its staff.
The FTC sued to block the merger between the two New Jersey-based health systems and won a preliminary injunction earlier this month. But the providers believe that the merger would not raise prices or stifle competition — like the FTC alleges it would — and have filed an appeal.
Here are three ways technology is changing post-pandemic care for seniors and vulnerable populations.
Pfizer has preliminary data showing its experimental drug for atopic dermatitis beat a blockbuster drug from Regeneron Pharmaceuticals in a head-to-head clinical trial. But the future of that drug and others might depend more on an FDA review of safety data for medicines in this class of so-called JAK inhibitors.
The goal is not to enable a robot to perform complex surgeries without human involvement. But using surgical robotics to democratize access to quality care to underserved communities is an outcome that we can achieve and which the world needs.
Peer support is always there to empower people to take the next steps on their path to a healthier, happier existence.
As net patient revenue declined, operating expenses rose 5% from 2019 to 2020, according to an analysis of financial statements from the 25 largest nonprofit health systems in the U.S.
Full FDA approval of Pfizer and BioNTech’s Covid-19 vaccine was the biggest news in a busy week for coronavirus vaccines, drugs, and diagnostics. Here’s a look back at some of the major developments.
The company currently has two incubating startups, Violet, a bank to help people with medical bills, and Rotera, an AI consulting firm for health systems.
The Department of Justice and the Department of Homeland Security subpoenaed the company for information related to its reporting of injuries, Peloton disclosed in an SEC filing on Friday. The company recalled its line of treadmills earlier this year after multiple reports of injuries and one death.
The company offers clinical triage via an artificial intelligence-powered chatbot and unlimited virtual visits through a majority of its plans. Inspired by the Israeli healthcare system, patients on Antidote plans pay a monthly membership fee.
The European Commission has approved a BioMarin Pharmaceutical drug that treats achondroplasia, a rare genetic disorder that slows bone growth and is the most common cause of dwarfism. The commission also granted conditional approval to a cancer drug from partners Incyte and MorphoSys.
Clinical trials are the safest and most trusted route for identifying new breast cancer treatments, and the more research that can be done, the closer we will be to eradicating breast cancer for good.
Check out new developments from HealthMine, Seven Bridges, Lemonaid Health,
Read more to find out which finalists will present in the startup pitch contest during the conference, which will be virtual, and is scheduled for September 20-23.
The startup is working with Curebase to launch five clinical trials to test its VR-based therapeutic for chronic pain. They plan to enroll a total of more than 2,000 people.
As a result of the partnership, clinicians using Epic will be able to order Foundation Medicine’s genomic profiling tests directly from the EHR and view results in the system, providing them with clinical decision support.
Atavistik Bio is one of several companies discovering and developing drugs that work by allostery, binding to less obvious sites of a target protein. Acting CEO John Josey said the startup aims to stand apart with its focus on understanding metabolic interactions, a path less trodden by others in allosteric drug discovery.
Providers must report how they spent funding received via the CARES Act by Sept. 30, but they are still grappling with questions related to what expenses need to be reported amid shifting government guidance.
The royalty agreement with HealthCare Royalty Partners will support ADC Therapeutics’ plans to commercialize its newly approved cancer drug and develop the next one in its pipeline. The biotech’s drug Zynlonta is the first of its type approved by the FDA as a treatment for diffuse large cell B-cell lymphoma
They plan to commercialize the decision support software, which would surface relevant patient records and recommendations from Mayo Clinic specialists. To start, they will focus on cardiometabolic conditions.
The increase in access to public health insurance coverage — via legislation like the Families First Coronavirus Response Act that prevents states from disenrolling Medicaid beneficiaries — helped offset the loss of employer-sponsored insurance, the report from Robert Wood Johnson Foundation shows.
The company makes software to spot diagnostic errors in radiology and route patients to centers of excellence.
Eli Lilly is entering the field of protein-degrading drugs through a partnership with Lycia Therapeutics, a startup whose technology goes further than the first wave of such drugs. Lilly paid $35 million to begin the alliance, which spans up to five drugs.
Only through the adoption of cutting-edge technologies we can create personalized wound treatments in a way that meets the needs of the medical teams and also significantly improve the patient-experience and quality of life.
The two companies will merge to form Headspace Health, which will combine Headspace’s many meditation and wellness exercises with Ginger’s coaching and therapy services. The combined company will have more than 800 employees and a $3 billion valuation.
Through a program funded by Independence Blue Cross Foundation, 1,800 frontline healthcare workers across the three Pennsylvania-based hospitals will gain access to NeuroFlow’s technology, which will measure and track their mental health symptoms and provide support via educational resources and a clinical care team.
As U.S. plans for Covid-19 booster shots unfold, Johnson & Johnson is angling to join the mix, reporting data that it says support a second shot of its vaccine. But the data the company points to are sparse and it’s not entirely clear they support booster shots.
Each Organ-Chip is a transparent, flexible microenvironment that contains two parallel chambers that can be configured to grow human cells from an organ of interest, such as the liver, kidney proximal tubule, intestine, lung and brain
Despite these seven headwinds, the medical device market has strong momentum headed into 2022 and beyond.
The Knowledge Hub from MedCity News is designed to help you get targeted healthcare leads and scale your business, at no upfront cost to you.
Among the large, claims-based study’s findings was a dramatic 62% lower medical spend, 89% lower opioid use, and 51% lower use of antidepressants for Kiio participants.
Chronic kidney disease patients who experience pruritus after dialysis can now get relief from the first FDA-approved treatment for the condition. Cara Therapeutics received the FDA’s nod green light for its injectable drug, Korsuva.
Called Novasenta, the company is focused on the tumor microenvironment and will leverage its machine-learning platform to pinpoint targets for drug development. It aims to launch its first clinical trial by the end of 2023.
The company is buying two urgent care chains in Tuscon, Arizona and Sacramento, California. It now has 83 clinics in 12 states, as it looks to go toe-to-toe with other primary care competitors.
Now, Covid-19 vaccine administrators can earn an additional $35 per vaccination for up to five Medicare beneficiaries who live in a communal living space, like smaller group homes or assisted living facilities. CMS aims to boost vaccination rates with this pay increase.
The startup, which is focused on letting patients share their health records for rare disease research, plans to use the funds to launch 100 rare disease programs.
Consider this scenario. Two 60-year old women live 10 miles apart in the Washington DC […]
The Theravance Biopharma drug is the lead program in an alliance with Johnson & Johnson subsidiary Janssen Biotech, which paid $100 million up front to develop the JAK inhibitor for intestinal diseases. Following the Phase 2 failure, Theravance said it will minimize spending on that program.
CMS recently revealed that the Patient-Driven Payment Model – intended to be revenue-neutral as compared to the previous payment model – increased reimbursements to SNFs last year by more than $1.7 billion, raising the specter of potential payment reviews around the corner.
INVEST Digital Health is set for September 20-23, and held in collaboration with Medical Alley. It brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.
The tech giant plans to dissolve its health division with the departure of leader Dr. David Feinberg. But Google maintains that healthcare is still a big focus for the company, and that the division’s projects and staff would continue under other leaders.
The report, released by Kaiser Family Foundation and the Peterson Center on Healthcare, details the high cost of Covid care for the unvaccinated. In fact, the analysis indicates the figure could be even higher than $2.3 billion, as the authors did not take into account the cost of outpatient treatment for Covid-19.
Though Gilead Sciences leads the group of companies developing immunotherapies that target the cancer protein CD47, Pfizer contends that molecules it is getting through the Trillium Therapeutics acquisition have safety and efficacy advantages that could make them the best in this emerging drug class.
A consortium of investors, led by Nordic Capital and Insight Partners, plan to acquire the company in a deal that would value it at $7.3 billion. It’s expected to close later this year or in early 2022.
Two lawsuits, filed by the U.S. Chamber of Commerce and the Pharmaceutical Care Management Association, allege that portions of the price transparency rule governing insurers are unlawful and would drive up healthcare prices, contrary to the rule’s stated aim.
Creating an effective loyalty strategy can deliver on consumer needs while creating a personalized experience that will help establish deeper relationships between patients, healthcare systems and providers.
Full FDA approval makes the Pfizer/BioNTech Covid-19 vaccine the first to reach that milestone. But the regulatory decision also flagged a potential risk of heart inflammation, particularly in young males, and the agency has asked the companies to conduct additional clinical research.
CG Oncology CEO Arthur Kuan talked about the biotech company’s experimental bladder cancer treatment in Phase 3 development and collaboration with Merck, among the company’s milestones, in response to emailed questions.
The clock is ticking down for payers and providers to comply with the No Surprises Act, which protects patients from balance billing for the most common ancillary medical services. Here’s how to get your ducks in a row.
Several pharmacies signed a letter asking Surescripts’ board to rescind its deal with GoodRx. They said the deal would not reveal the true cost of medications, and might steer patients away from independent pharmacies.
In a wide-ranging interview, Dr. Scott Weingarten, the payer’s inaugural chief innovation officer, discussed his priorities in his new role, including the new payer-agnostic geriatric primary care group he will help launch.
Vigil Neuroscience led the way with a $90 million round of funding, one of four biotech companies to close Series B financing rounds in the past week. The fresh capital comes as each of the companies looks ahead to bringing their respective drugs into the clinic.
While the healthcare system has its share of struggles nationwide, the problem is especially severe in rural areas where there is a shortage of physicians and some hospitals are closing permanently.
An AstraZeneca antibody drug for Covid-19 has clinical data showing the drug reduced the risk of infection by 77%. With the results, the pharmaceutical giant pulls ahead of other companies developing injectable versions of antibody drugs for Covid-19 prevention.
Feinberg comes to Cerner from Google Health, which he has led since 2019. The move comes amid news reports that Google plans to dismantle its health division.
Alexion Pharmaceuticals drug Ultomiris is already approved to treat a rare blood disorder, but the company hoped the antibody’s approach could also work in amyotrophic lateral sclerosis. Despite failing in ALS, Alexion, recently acquired by AstraZeneca, brings additional clinical-stage programs for rare diseases.
MedCity News has launched the Knowledge Hub to help you get targeted healthcare leads and scale your business, at no upfront cost to you.
Here are three ways to develop leaders capable of effectively fostering a healthy work environment where it matters most – at the front lines of patient care.
Read about new developments from Kiio, Healthmine, MiSalud, bttn and more.
Bright Health will use proceeds from its IPO to fund the expansion, which will bring its total number of markets to 141 from 99. The company will also expand its product portfolio in states where it already operates.
Founders Alessandra Henderson and Jannine Versi set out to build a digital health platform for people who are going through menopause. The New York-based startup recently raised $3.75 million in funding.
In closing its Grail acquisition before U.S. and European regulators sign off, Illumina is taking a chance the deal will pass regulatory muster. It’s a potentially pricey gambit, as Illumina could face fines for its early action and there are no assurances that regulators will agree that the deal is not anticompetitive.
Partnering with private consulting firms can spur greater hospital participation in the Bundled Payments for Care Improvement initiative Advanced Model, in which hospitals earn rewards for spending less than CMS-set benchmarks on an episode of care or pay penalties if they spend more.
Overturning a district court’s decision that had earlier vacated the Medicare Advantage Overpayment Rule, the DC Circuit opened a Pandora’s Box of DOJ False Claims Act litigation last week.
The company is licensing out technology from Australian digital health company TALi Digital to improve attention in early childhood. Akili will pay $37.5 million, including milestone payments and royalties.
As plans struggle to decide how to comply with a badly-worded portion of the final rule on interoperability, they should be thinking about the broader changes at work and whether their choices now prepare them for the world ahead.
In announcing plans to offer Covid-19 booster shots, federal health officials cited declining vaccine efficacy shown by real-world studies. But the World Health Organization said the science is less than clear about booster shots, adding that it’s ethically wrong to give third shots when so many around the world are waiting for their first one.
According to two new reports, hospital admissions were about 85% of what was expected based on historic patterns at the beginning of April, and in the same month, 11% of adults reported delaying care because of Covid, including 16% of Hispanic and 13% of Black adults.
Carrot Fertility raised $75 million in a funding round led by Tiger Global Management. Investors have been pouring more funds into fertility benefits as employers look to win over talent.
Called the Innovator Community Expansion Initiative, the main goal of the effort is to pinpoint and remove obstacles keeping underrepresented groups, like women, out of the innovation process. The initiative will promote networking and education about the path to commercialization.
Personalizing your EHR is a proven best practice for new implementations and major system upgrades. These four new approaches boost physician satisfaction and improve EHR usability.
GlaxoSmithKline drug Jemperli is now FDA approved for treating solid tumors throughout the body as long as they have a particular genetic signature. Expanding the drug’s approval means the drug can treat more patients who have more types of cancer, and it also gives GSK a way to grow revenue in its thin oncology portfolio.
ClosedLoop.ai, an Austin-based healthcare startup, raised new funding after being picked by CMS as the winner of its AI Health Outcomes Challenge. The company’s secret? Working with health systems to build algorithms that are explainable.
To realize its care coordination ambitions, Elevate enlisted the help of the Innovaccer Health Cloud, which unifies member data across systems and care settings.
HCA plans to sell PatientKeeper, which makes physician workflow software, to health IT startup Commure. The hospital chain will get a minority stake in the combined company.
The company, which provides telemedicine and digital programs focused on maternal health, will use the funds raised to expand its services to new populations, including international patients and Medicaid members.
Verily’s recent moves have signaled the company’s interest in supporting decentralized clinical trials and real-world studies. Now the life sciences subsidiary of Alphabet is bolstering its capabilities in this these areas with the acquisition of startup SignalPath.
Infrequent communication about Covid-19 and slow adoption of virtual care were the most common reasons cited by patients when asked why they lost confidence in their doctor, according to the survey conducted by SymphonyRM.
Gritstone bio is developing Covid-19 vaccines that use self-amplifying messenger RNA, which is intended to further boost the immune response compared to mRNA alone. The company also says its vaccine candidates may be able to protect against variants of the novel coronavirus.
As long as providers remain HIPAA-compliant, they will be able to text patients with ease and see all the benefits that it brings — including stronger patient loyalty, more revenue, and more referrals.
Unite Us, which uses technology to connect healthcare and social services, acquired Carrot Health, which combines large consumer and health datasets.
INVEST Digital Health is set for September 20-23, and held in collaboration with Medical Alley. It brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.
Abbott Laboratories received FDA approval for its Amulet device to treat people with atrial fibrillation who are at risk of ischemic stroke. The device would go head-to-head with one developed by Boston Scientific that was approved in 2015.
Much like COVID-19 forced us all to slow down, to have more meaningful conversations and collaborations, so, too, did HIMSS21.
Startup HiberCell has acquired Genuity Science, a marriage that brings together two companies that apply AI and machine learning to drug research. HiberCell says Genuity will help the company identify and validate new pathways in how cancer starts and progresses.
The ongoing battle the world faces with the Covid-19 pandemic continues. While progress is being […]
The senior care provider currently operates 34 medical centers offering healthcare and social services, like transportation. Through the collaboration, the companies will bring more seniors into value-based arrangements with the goal of improving outcomes for Anthem patients.
The company purchased digital health company Ovia Health for an undisclosed amount. It makes apps for fertility tracking, pregnancy stages and parenting advice.
The permanent injunction prevents HHS from interpreting a section of the ACA, which bans discrimination, to include gender identity and pregnancy status. This move prohibits the federal agency from penalizing religious providers for refusing to perform or provide insurance coverage for gender-transition surgeries and abortions.
For much of this summer, Sesen Bio said all of the FDA’s communications pointed toward regulatory approval for the biotech’s bladder cancer drug. Though Sesen characterized the regulator’s rejection of the fusion protein as surprising, CEO Tom Cannell also revealed an earlier sign that another clinical trial may be necessary.
The mHUB MedTech Accelerator is a six-month program, based in Chicago, run in partnership with Baxter and Edward-Elmhurst Health Venture Capital. The application deadline is Monday, August 23.
At the intersection of health tech and diagnostics, hc1’s CEO Brad Bostic talked about the company’s origins and how it works with medical laboratories, hospitals and health plans.
FDA approval of the Merck drug, belzutifan, covers treatment of tumors caused by von Hippel-Lindau disease, an inherited disorder associated with several types of cancer. Merck added the small molecule to its pipeline two years ago as part of a $1.2 billion acquisition.
Homelessness, a key social determinant of health, is on the rise, prompting action from payers and providers. Though their efforts are varied, ranging from subsidizing housing to making it easier for those living in encampments or temporary housing to access care, they have a common goal.
The agency is rolling back emergency use authorizations for some Covid-19 tests, and decontamination systems used to sterilize N95 masks for re-use, among other devices. Hospitals will need a system to keep close track of which devices they’re using and which ones are no longer authorized.
UnitedHealthcare and United Behavioral Health agreed to the settlement to resolve allegations that they illegally denied coverage for mental health and substance use disorder treatments. The allegations are related to business practices they no longer use, parent company UnitedHealth Group said.
Zoom recently reached an $85 million settlement agreement for a lawsuit alleging the company shared users’ data and misrepresented encryption claims. It should be a lesson for the industry that health data cannot be used with disregard, a security expert said.
Covid-19 vaccine booster shots are now authorized for organ transplant patients and others who have weakened immune systems. The FDA based its update on the results of two small studies that tested third shots of the mRNA Covid vaccines from Moderna and Pfizer/BioNTech.
Read about new developments from HealthMine, Carrum Health, Encellin and more.
The NowPow referral platform, which is integrated into the New Jersey-based health system’s EHR, will enable clinicians and other care team members to provide patients — whose socioeconomic conditions are negatively affecting their health — with referrals to community resources, like food banks or rental assistance.
FDA approval of a therapy that pairs drugs from Eisai and Merck allows the combination to become a first-line treatment for renal cell carcinoma. It’s the latest approval for the partners, which have been working together since 2018.
The home care platform brought in $5 million in revenue last year. Sharecare plans to sell the service to its health plans and provider customers.
In a remote work environment, cybersecurity teams learned that they needed to support their organizations by providing workers with the information they needed to secure their data, while also remaining flexible to changing needs, panelists said at a HIMSS Digital session.
Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for Intersect ENT’s products and elective procedures returning over the summer months might have helped the deal cross the finish line.
The new CMS Mandate on CDSM takes effect on January 1, 2022. Is your organization ready for compliance when ordering outpatient advanced imaging?
For the second time in a week, the FDA placed a clinical hold on an Aprea Therapeutics cancer drug. The biotech said the agency cited safety and efficacy data from a prior failed clinical trial that tested the small molecule in a different form of cancer.
Molecular testing labs are becoming much more prominent and one reason for their rise is an increased emphasis on evidence-based precision medicine.
A recent survey from Foxit Software suggests that the legal argument for maintaining paper-based medical documents is not going away.
At the start of the pandemic, the lack of integration between IT systems was painful, said Dr. Anne Zink, chief medical officer for the state of Alaska, at HIMSS Digital. She hopes the pandemic will shed a light on the importance of information sharing between public health and health systems.
A class-action lawsuit, filed by six North Carolina residents, alleges that HCA Healthcare bought Mission Health to gain monopolistic control in the Western part of the state, enabling it to drive up prices while lowering the quality of care.
The plans, which will be offered by Aetna, are based on Teladoc’s physician care team model, and also includes providers through Aetna’s network and CVS Health services.
In a HIMSS 21 Digital session, panelists detailed the dichotomy of technology advancement for clinicians. Though technology has made it harder for them to disconnect from work leading to burnout, IT tools can also be used to identify pain points and implement solutions to alleviate stress.
It’s essential for physicians to consider the circumstances of their patient’s life while communicating the treatment plan and engage them with dialogue that addresses any challenges or hesitations that they may have to achieve medication adherence.
One of many sweeping regulatory changes made in the last year, a rule for CMS to cover breakthrough devices that have been approved by the FDA has been kicked back to this fall. Two former officials with CMS and the FDA shared what considerations the agencies will be making as they review this policy.
In a virtual keynote during HIMSS, Northwell Health CEO Michael Dowling highlighted the importance of agility, the urgent need for technology and the benefits of having the support of a large integrated system during a pandemic.
Technological innovations have enabled the adoption of decentralized and hybrid clinical trial models (DCTs) at […]
The pandemic made collaboration necessary between stakeholders that otherwise tend to be at odds with each other. But as partnerships grow, providers, payers and pharma companies must ensure they are working toward a clear-cut common goal, according to panelists at HIMSS 21 Digital.